Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Indefinite-Lived Intangible Assets by Quarter
Indefinite-Lived Intangible Assets (IPR&D & Brands) — Carrying amount ($M) ($M)
Pfizer Indefinite-Lived Intangible Assets: $17,780M in Q2 2026, down 4.8% from a year earlier.
Latest, Q2 2026
17,780
Period ended Jun 28, 2026
Change on a year earlier
-4.8%
18,674 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
45
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Goodwill & Other Intangible Assets Footnote.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Indefinite-Lived Intangible Assets (IPR&D & Brands) — Carrying amount ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 17,780 | -4.8% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 21,641 | +11.8% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 22,221 | +13.6% | Form 10-Q (filed 2026-08-04) ↗ |
| Q3 2025 | Sep 28, 2025 | 17,811 | -21.4% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 18,674 | -17.5% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 19,353 | -15.6% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 19,563 | -21.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 22,646 | +82.7% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 22,646 | +82.7% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 22,930 | +78.3% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 24,784 | +88.4% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 12,394 | +28.7% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | 12,395 | +26.1% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 12,860 | +29.6% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 13,155 | +196.8% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2022 | Oct 2, 2022 | 9,629 | +114.0% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 9,829 | +116.7% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 9,922 | +118.8% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | 4,432 | -3.1% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2021 | Oct 3, 2021 | 4,500 | -22.2% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2021 | Jul 4, 2021 | 4,535 | -35.5% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2021 | Apr 4, 2021 | 4,535 | -49.5% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2020 | Dec 31, 2020 | 4,575 | -41.5% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2020 | Sep 27, 2020 | 5,785 | -35.9% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 28, 2020 | 7,032 | +77.8% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 29, 2020 | 8,982 | +120.4% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2019 | Dec 31, 2019 | 7,819 | +87.7% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2019 | Sep 29, 2019 | 9,023 | -2.9% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2019 | Jun 30, 2019 | 3,954 | -67.3% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 4,076 | -66.5% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 4,165 | -65.8% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 9,294 | -24.0% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jul 1, 2018 | 12,090 | -1.8% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Apr 1, 2018 | 12,153 | -2.1% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 12,179 | -28.3% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2017 | Oct 1, 2017 | 12,229 | -30.1% | SEC Filing ↗ |
| Q2 2017 | Jul 2, 2017 | 12,315 | -2.5% | SEC Filing ↗ |
| Q1 2017 | Apr 2, 2017 | 12,418 | +53.8% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 16,984 | +107.3% | Form 10-K (filed 2018-02-22) ↗ |
| Q3 2016 | Oct 2, 2016 | 17,487 | +105.2% | SEC Filing ↗ |
| Q2 2016 | Jul 3, 2016 | 12,631 | +65.3% | SEC Filing ↗ |
| Q1 2016 | Apr 3, 2016 | 8,072 | +5.7% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 8,192 | – | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2015 | Sep 27, 2015 | 8,522 | – | SEC Filing ↗ |
| Q2 2015 | Jun 28, 2015 | 7,642 | – | SEC Filing ↗ |
| Q1 2015 | Mar 29, 2015 | 7,640 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Pfizer Indefinite-Lived Intangible Assets ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/iprd-tot
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.